Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 175

1.

Determinants of human papillomavirus vaccine attitudes: an interview of Wisconsin parents.

Barnes KL, VanWormer JJ, Stokley S, Vickers ER, McLean HQ, Belongia EA, Bendixsen CG.

BMC Public Health. 2018 Jun 15;18(1):746. doi: 10.1186/s12889-018-5635-y.

PMID:
29907115
2.

Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018.

Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Foust A, Sessions W, Berman L, Barnes JR, Spencer S, Fry AM.

Am J Transplant. 2018 Apr;18(4):1020-1025. doi: 10.1111/ajt.14730. No abstract available.

PMID:
29603606
3.

Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines.

Dooling KL, Guo A, Patel M, Lee GM, Moore K, Belongia EA, Harpaz R.

Am J Transplant. 2018 Mar;18(3):756-762. doi: 10.1111/ajt.14683. No abstract available.

PMID:
29462512
4.

Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.

Flannery B, Chung JR, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Foust A, Sessions W, Berman L, Barnes JR, Spencer S, Fry AM.

MMWR Morb Mortal Wkly Rep. 2018 Feb 16;67(6):180-185. doi: 10.15585/mmwr.mm6706a2.

5.

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.

Russell K, Chung JR, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Flannery B.

Vaccine. 2018 Feb 28;36(10):1272-1278. doi: 10.1016/j.vaccine.2018.01.045.

PMID:
29402578
6.

Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.

King JP, McLean HQ, Meece JK, Levine MZ, Spencer SM, Flannery B, Belongia EA.

Vaccine. 2018 Feb 21;36(9):1214-1219. doi: 10.1016/j.vaccine.2018.01.016.

PMID:
29395525
7.

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.

Dooling KL, Guo A, Patel M, Lee GM, Moore K, Belongia EA, Harpaz R.

MMWR Morb Mortal Wkly Rep. 2018 Jan 26;67(3):103-108. doi: 10.15585/mmwr.mm6703a5.

8.

Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.

Flannery B, Smith C, Garten RJ, Levine MZ, Chung JR, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Griffin MR, Keipp Talbot H, Treanor JJ, Wentworth DE, Fry AM.

J Infect Dis. 2018 Jan 18. doi: 10.1093/infdis/jix634. [Epub ahead of print]

PMID:
29361005
9.

Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.

Seagle EE, Bednarczyk RA, Hill T, Fiebelkorn AP, Hickman CJ, Icenogle JP, Belongia EA, McLean HQ.

Vaccine. 2018 Feb 1;36(6):818-826. doi: 10.1016/j.vaccine.2017.12.075. Epub 2018 Jan 6.

PMID:
29317117
10.

Burden of medically attended influenza infection and cases averted by vaccination - United States, 2013/14 through 2015/16 influenza seasons.

Jackson ML, Phillips CH, Benoit J, Jackson LA, Gaglani M, Murthy K, McLean HQ, Belongia EA, Malosh R, Zimmerman R, Flannery B.

Vaccine. 2018 Jan 25;36(4):467-472. doi: 10.1016/j.vaccine.2017.12.014. Epub 2017 Dec 14.

11.

An updated influenza A(H3N2) vaccine generates limited antibody responses to previously encountered antigens in children.

Florek NW, Campos LM, Braun KM, McLean HQ, King JP, Flannery B, Belongia EA, Friedrich TC.

Vaccine. 2018 Jan 29;36(5):758-764. doi: 10.1016/j.vaccine.2017.12.024. Epub 2017 Dec 15.

PMID:
29249543
12.

Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons-United States, 2011-2016.

Stewart RJ, Flannery B, Chung JR, Gaglani M, Reis M, Zimmerman RK, Nowalk MP, Jackson L, Jackson ML, Monto AS, Martin ET, Belongia EA, McLean HQ, Fry AM, Havers FP.

Clin Infect Dis. 2018 Mar 19;66(7):1035-1041. doi: 10.1093/cid/cix922.

PMID:
29069334
13.

Pilot screening study of targeted genetic polymorphisms for association with seasonal influenza hospital admission.

Carter TC, Hebbring SJ, Liu J, Mosley JD, Shaffer CM, Ivacic LC, Kopitzke S, Stefanski EL, Strenn R, Sundaram ME, Meece J, Brilliant MH, Ferdinands JM, Belongia EA.

J Med Virol. 2018 Mar;90(3):436-446. doi: 10.1002/jmv.24975. Epub 2017 Nov 11.

PMID:
29053189
14.

Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness.

Belongia EA.

J Infect Dis. 2017 Dec 19;216(12):1477-1480. doi: 10.1093/infdis/jix527. No abstract available.

PMID:
29029175
15.

2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.

Poehling KA, Caspard H, Peters TR, Belongia EA, Congeni B, Gaglani M, Griffin MR, Irving SA, Kavathekar PK, McLean HQ, Naleway AL, Ryan K, Talbot HK, Ambrose CS.

Clin Infect Dis. 2018 Feb 10;66(5):665-672. doi: 10.1093/cid/cix869.

16.

Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents.

VanWormer JJ, Bendixsen CG, Vickers ER, Stokley S, McNeil MM, Gee J, Belongia EA, McLean HQ.

BMC Public Health. 2017 Oct 2;17(1):766. doi: 10.1186/s12889-017-4787-5.

17.

Estimated rates of influenza-associated outpatient visits during 2001-2010 in 6 US integrated healthcare delivery organizations.

Zhou H, Thompson WW, Belongia EA, Fowlkes A, Baxter R, Jacobsen SJ, Jackson ML, Glanz JM, Naleway AL, Ford DC, Weintraub E, Shay DK.

Influenza Other Respir Viruses. 2018 Jan;12(1):122-131. doi: 10.1111/irv.12495. Epub 2018 Feb 15.

18.

Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12.

Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, Cheetham TC, Glanz JM, Jackson LA, Klein NP, Naleway AL, Weintraub E, Belongia EA.

Vaccine. 2017 Sep 25;35(40):5314-5322. doi: 10.1016/j.vaccine.2017.06.069.

PMID:
28917295
19.

Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink.

Vickers ER, McClure DL, Naleway AL, Jacobsen SJ, Klein NP, Glanz JM, Weintraub ES, Belongia EA.

Vaccine. 2017 Oct 13;35(43):5872-5877. doi: 10.1016/j.vaccine.2017.08.086. Epub 2017 Sep 6.

PMID:
28888342
20.

Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season.

Jackson ML, Chung JR, Jackson LA, Phillips CH, Benoit J, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Murthy K, Zimmerman R, Nowalk MP, Fry AM, Flannery B.

N Engl J Med. 2017 Aug 10;377(6):534-543. doi: 10.1056/NEJMoa1700153.

Supplemental Content

Loading ...
Support Center